Substrate Specificity of the Sialic Acid Biosynthetic Pathway
- 1 October 2001
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 40 (43) , 12864-12874
- https://doi.org/10.1021/bi010862s
Abstract
Unnatural analogues of sialic acid can be delivered to mammalian cell surfaces through the metabolic transformation of unnatural N-acetylmannosamine (ManNAc) derivatives. In previous studies, mannosamine analogues bearing simple N-acyl groups up to five carbon atoms in length were recognized as substrates by the biosynthetic machinery and transformed into cell surface sialoglycoconjugates [Keppler, O. T., et al. (2001) Glycobiology 11, 11R-18R]. Such structural alterations to cell surface glycans can be used to probe carbohydrate-dependent phenomena. This report describes our investigation into the extent of tolerance of the pathway toward additional structural alterations of the N-acyl substituent of ManNAc. A panel of analogues with ketone-containing N-acyl groups that varied in the length or steric bulk was chemically synthesized and tested for metabolic conversion to cell surface glycans. We found that extension of the N-acyl chain to six, seven, or eight carbon atoms dramatically reduced utilization by the biosynthetic machinery. Likewise, branching from the linear chain reduced metabolic conversion. Quantitation of metabolic intermediates suggested that cellular metabolism is limited by the phosphorylation of the N-acylmannosamines by ManNAc 6-kinase in the first step of the pathway. This was confirmed by enzymatic assay of the partially purified enzyme with unnatural substrates. Identification of ManNAc 6-kinase as a bottleneck for unnatural sialic acid biosynthesis provides a target for expanding the metabolic promiscuity of mammalian cells.Keywords
This publication has 16 references indexed in Scilit:
- Molecular cloning and characterization of murine and human N‐acetylglucosamine kinaseEuropean Journal of Biochemistry, 2000
- Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells.Glycobiology, 2000
- Selective Loss of either the Epimerase or Kinase Activity of UDP-N-acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase due to Site-directed Mutagenesis Based on Sequence AlignmentsJournal of Biological Chemistry, 1999
- Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast ReagentsJournal of the American Chemical Society, 1999
- CMP–3‐Deoxy‐d‐Glycerol‐d‐Galacto‐Nonulosonic Acid (CMP‐Kdn) SynthetaseEuropean Journal of Biochemistry, 1996
- Biosynthetic Modulation of Sialic Acid-dependent Virus-Receptor Interactions of Two Primate Polyoma VirusesJournal of Biological Chemistry, 1995
- Synthesis of potential inhibitors of hemagglutination by influenza virus: chemoenzymic preparation of N-5 analogs of N-acetylneuraminic acid.Tetrahedron, 1993
- Inhibitors of liver lysosomal acid phospholipase A1European Journal of Biochemistry, 1988
- Activation and transfer of novel synthetic 9‐substituted sialic acidsEuropean Journal of Biochemistry, 1987
- Preparation of 9‐fluoro‐9‐deoxy‐N‐[2‐14C]acetylneuraminic acidFEBS Letters, 1984